Max Healthcare Institute 관리

관리 기준 확인 2/4

Max Healthcare Institute CEO는 Abhay Soi, Jun2020 에 임명되었습니다 의 임기는 4.42 년입니다. 총 연간 보상은 ₹ 247.33M, 79.7% 로 구성됩니다. 79.7% 급여 및 20.3% 보너스(회사 주식 및 옵션 포함). 는 ₹ 230.73B 가치에 해당하는 회사 주식의 23.74% 직접 소유합니다. 230.73B. 경영진과 이사회의 평균 재임 기간은 각각 5.1 년과 3.5 년입니다.

주요 정보

Abhay Soi

최고 경영자

₹247.3m

총 보상

CEO 급여 비율	79.7%
CEO 임기	4.4yrs
CEO 소유권	23.7%
경영진 평균 재임 기간	5.1yrs
이사회 평균 재임 기간	3.5yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Abhay Soi 의 보수는 Max Healthcare Institute 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Sep 30 2024	n/a	n/a	₹11b
Jun 30 2024	n/a	n/a	₹11b
Mar 31 2024	₹247m	₹197m	₹11b
Dec 31 2023	n/a	n/a	₹11b
Sep 30 2023	n/a	n/a	₹10b
Jun 30 2023	n/a	n/a	₹12b
Mar 31 2023	₹140m	₹140m	₹11b
Dec 31 2022	n/a	n/a	₹10b
Sep 30 2022	n/a	n/a	₹9b
Jun 30 2022	n/a	n/a	₹6b
Mar 31 2022	₹140m	₹49m	₹6b
Dec 31 2021	n/a	n/a	₹6b
Sep 30 2021	n/a	n/a	₹5b
Jun 30 2021	n/a	n/a	₹3b
Mar 31 2021	₹117m	₹91m	-₹1b

보상 대 시장: Abhay 의 총 보상 ($USD 2.93M )은 Indian 시장( $USD 1.10M ).

보상과 수익: Abhay 의 보상은 지난 1년 동안 20% 이상 증가했습니다.

CEO

Abhay Soi (51 yo)

4.4yrs

테뉴어

₹247,330,308

보상

Mr. Abhay Soi is a Co-Founder of Halcyon Group. He served as Executive Officer at Ernst & Young LLP. Mr. Soi served as Head of Financial Restructuring group at Ernst & Young and Arthur Anderson.He has in-...

리더십 팀

이름	위치	테뉴어	보상	소유권
Abhay Soi	Chairman & MD	4.4yrs	₹247.33m	23.74% ₹ 230.7b
Yogesh Sareen	Senior Director & CFO	12.8yrs	₹45.10m	0.0062% ₹ 60.0m
Dhiraj Aroraa	Senior VP	1.8yrs	₹10.00m	데이터 없음
Mradul Kaushik	Member of Group Medical Advisory Council	no data	데이터 없음	데이터 없음
Prashant Singh	Director of Information Technology & Chief Information Officer	5.2yrs	데이터 없음	데이터 없음
Gagan Palta	General Counsel & Director	less than a year	데이터 없음	데이터 없음
Anas Wajid	Senior Director and Chief Sales & Marketing Officer	no data	데이터 없음	데이터 없음
Umesh Gupta	Member of Group Medical Advisory Council	5.3yrs	데이터 없음	데이터 없음
Sandeep Budhiraja	Member of Group Medical Advisory Council & Group Medical Director	no data	데이터 없음	데이터 없음
Sanjiv K. Marya	Member of Group Medical Advisory Council	5.1yrs	데이터 없음	데이터 없음
Anurag Krishna	Chairman of Paediatrics & Paediatric Surgery	3.8yrs	데이터 없음	데이터 없음
Harinder Chehal	Senior Director & COO - Cluster 2	5.3yrs	데이터 없음	데이터 없음

5.1yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 관리: 543220 의 관리팀은 노련하고 경험 (평균 재직 기간 5.1 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Abhay Soi	Chairman & MD	5.4yrs	₹247.33m	23.74% ₹ 230.7b
Mradul Kaushik	Member of Group Medical Advisory Council	no data	데이터 없음	데이터 없음
Gagan Palta	General Counsel & Director	less than a year	데이터 없음	데이터 없음
Umesh Gupta	Member of Group Medical Advisory Council	no data	데이터 없음	데이터 없음
Sandeep Budhiraja	Member of Group Medical Advisory Council & Group Medical Director	no data	데이터 없음	데이터 없음
Sanjiv K. Marya	Member of Group Medical Advisory Council	no data	데이터 없음	데이터 없음
N. Venkatesan	Director & Chief Procurement Officer	no data	데이터 없음	데이터 없음
Mahendra Lodha	Non-Executive Independent Director	5.4yrs	₹5.25m	데이터 없음
Narayan Seshadri	Non-Executive Non-Independent Director	1.5yrs	₹3.83m	데이터 없음
Pradeep Chowbey	Member of Group Medical Advisory Council	no data	₹4.42m	데이터 없음
Harit Chaturvedi	Member of Group Medical Advisory Council	no data	데이터 없음	데이터 없음
Dinesh Khullar	Member of Group Medical Advisory Council	no data	데이터 없음	데이터 없음

3.5yrs

평균 재임 기간

57.5yo

평균 연령

경험이 풍부한 이사회: 543220 의 이사회는 경험(평균 재직 기간 3.5 년)으로 간주됩니다.

Max Healthcare Institute 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Max Healthcare Institute Limited Cessation of Gautam Wadhwa as Director

Max Healthcare Institute Limited Appoints Kummamuri Narasimha Murthy as an Independent Director

Insufficient new directors

Max Healthcare Institute Limited, Annual General Meeting, Sep 20, 2024

Max Healthcare Institute Limited Announces Change in Management

Max Healthcare Institute Limited, Annual General Meeting, Sep 27, 2023

Recent updates

Consensus revenue estimates increase by 13%

Max Healthcare Institute Limited (BSE:543220) acquired remaining 36.35% stake in Jaypee Healthcare Limited from Lakshdeep Investments & Finance Pvt. Ltd and Lakshdeep Infrastructure and Holding Private Limited for INR 2.3 billion.

Price target increased by 8.2% to ₹1,017

Second quarter 2025 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited Cessation of Gautam Wadhwa as Director

Max Healthcare Institute Limited (BSE:543220) completed the acquisition of 63.65% stake in Jaypee Healthcare Limited from Lakshdeep Investments & Finance Pvt. Ltd and Lakshdeep Infrastructure and Holding Private Limited for INR 4 billion.

Max Healthcare Institute Limited Appoints Kummamuri Narasimha Murthy as an Independent Director

Max Healthcare Institute Limited Announces Declaration of Final Dividend

Max Healthcare Institute Limited (BSE:543220) entered into a Strategic Collaboration Agreement to acquire 64% stake in Jaypee Healthcare Limited from Lakshdeep Investments & Finance Pvt. Ltd and Lakshdeep Infrastructure and Holding Private Limited for an enterprise value of INR 16.6 billion.

Insufficient new directors

Max Healthcare Institute Limited to Report Q2, 2025 Results on Nov 06, 2024

Upcoming dividend of ₹1.50 per share

Max Healthcare Institute Limited, Annual General Meeting, Sep 20, 2024

First quarter 2025 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q1, 2025 Results on Aug 01, 2024

Max Healthcare Institute Limited Recommends Final Dividend for the Financial Year 2023-24

Full year 2024 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q4, 2024 Results on May 22, 2024

Max Healthcare Institute Limited (BSE:543220) agreed to acquire Alexis Multi-speciality Hospital Private Limited for approximately INR 3720 million.

Price target increased by 11% to ₹767

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Nine Months, 2024 Results on Jan 31, 2024

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q2, 2024 Results on Nov 06, 2023

Max Healthcare Institute Limited Approves the Declaration of Final Dividend for the Financial Year Ended March 31, 2023

Max Healthcare Institute Limited Announces Change in Management

Max Healthcare Institute Limited Provides Update on Petition Filed by the Company Against Touch Healthcare Private Limited and Others

Max Healthcare Institute Limited, Annual General Meeting, Sep 27, 2023

Max Healthcare Institute Limited Announces Appointment of Amrita Gangotra as Additional Director (Non-Executive and Independent Woman Director)

Price target increased by 7.1% to ₹611

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q1, 2024 Results on Aug 07, 2023

Aster Eye $300 million India Stake Sale

Price target increased by 8.1% to ₹564

Full year 2023 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited to Report Q4, 2023 Results on May 16, 2023

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates increase by 12%

Max Healthcare Institute Limited Announces Executive Changes

Max Healthcare Institute Limited to Report Q3, 2023 Results on Feb 02, 2023

Blackstone, CVC Manipal, Max Reportedly Eye KIMS Stake

Max Healthcare Reportedly Eyeing AMRI Hospitals

Price target increased to ₹512

Price target increased to ₹498

KKR, Temasek Reportedly Vie for Care Hospitals; Deal Likely at $1 Billion

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Max Healthcare Institute Limited Announces Management Changes

Max Healthcare Institute Limited to Report Q2, 2023 Results on Nov 01, 2022

Max Healthcare Institute Limited Announces Resignation of Ruchi Mahajan as Company Secretary and Compliance Officer

Max Healthcare Institute Limited Announces Cessation of Prashant Kumar as Non-Executive Non-Independent Director

Investor sentiment improved over the past week

Max Healthcare Institute Limited Announces Resignation of Gaurav Trehan as Non-Executive Non-Independent Director

KKR Reportedly Plans to Exit Max Healthcare by Selling its Entire 27.54% Stake

Max Healthcare Institute Limited, Annual General Meeting, Sep 26, 2022

High number of new directors

Max Healthcare Institute Limited to Report Q1, 2023 Results on Aug 10, 2022

KKR Affiliate Not in Talks for Stake Sale in Max Health

KKR Reportedly May Sell Stake in Max

Full year 2022 earnings: EPS and revenues miss analyst expectations

Ontario Teachers' Pension Plan Board, Max Healthcare Reportedly Lead the Race for Sahyadri Hospitals

Ontario Teachers' Pension Plan Board, Max Healthcare Reportedly Lead the Race for Sahyadri Hospitals

Max Healthcare Institute Limited to Report Q4, 2022 Results on May 25, 2022

High number of new and inexperienced directors

High number of new directors

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Max Healthcare Institute Limited Announces Executive Changes

Max Healthcare Institute Limited to Report Q3, 2022 Results on Feb 12, 2022

Consensus forecasts updated

Price target increased to ₹444